Arbutus Biopharma Corp (ABUS)
3.63
-0.02
(-0.55%)
USD |
NASDAQ |
Nov 14, 16:00
3.63
0.00 (0.00%)
After-Hours: 20:00
Arbutus Biopharma Total Return Level: 3.65 for Nov. 13, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
November 13, 2024 | 3.65 |
November 12, 2024 | 3.64 |
November 11, 2024 | 3.73 |
November 08, 2024 | 3.75 |
November 07, 2024 | 3.73 |
November 06, 2024 | 3.92 |
November 05, 2024 | 3.96 |
November 04, 2024 | 3.87 |
November 01, 2024 | 3.96 |
October 31, 2024 | 3.845 |
October 30, 2024 | 3.94 |
October 29, 2024 | 4.04 |
October 28, 2024 | 4.05 |
October 25, 2024 | 3.97 |
October 24, 2024 | 4.05 |
October 23, 2024 | 4.06 |
October 22, 2024 | 4.03 |
October 21, 2024 | 4.07 |
October 18, 2024 | 4.15 |
October 17, 2024 | 4.12 |
October 16, 2024 | 4.20 |
October 15, 2024 | 4.11 |
October 14, 2024 | 3.86 |
October 11, 2024 | 3.88 |
October 10, 2024 | 3.79 |
Date | Value |
---|---|
October 09, 2024 | 3.76 |
October 08, 2024 | 3.77 |
October 07, 2024 | 3.73 |
October 04, 2024 | 3.84 |
October 03, 2024 | 3.85 |
October 02, 2024 | 3.90 |
October 01, 2024 | 3.83 |
September 30, 2024 | 3.85 |
September 27, 2024 | 3.83 |
September 26, 2024 | 3.96 |
September 25, 2024 | 3.91 |
September 24, 2024 | 4.02 |
September 23, 2024 | 4.04 |
September 20, 2024 | 4.02 |
September 19, 2024 | 4.14 |
September 18, 2024 | 4.13 |
September 17, 2024 | 4.08 |
September 16, 2024 | 4.26 |
September 13, 2024 | 4.47 |
September 12, 2024 | 4.31 |
September 11, 2024 | 4.56 |
September 10, 2024 | 4.56 |
September 09, 2024 | 4.49 |
September 06, 2024 | 4.55 |
September 05, 2024 | 4.51 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
0.9101
Minimum
Apr 03 2020
6.20
Maximum
Jul 23 2020
2.869
Average
2.82
Median
Jul 22 2020
Total Return Level Benchmarks
Biomarin Pharmaceutical Inc | 66.66 |
Amicus Therapeutics Inc | 10.38 |
Ionis Pharmaceuticals Inc | 37.80 |
GlycoMimetics Inc | 0.402 |
FibroGen Inc | 0.3306 |